Oncology Drug Advisory Committee - PDFSEARCH.IO - Document Search Engine

Oncology Drug Advisory Committee
Results: 151

#	Item
31	FDA Briefing Document Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (ODAC) November 5, 2013 DISCLAIMER STATEMENT The attached package contains background information prepared by the Food and D Add to Reading List Source URL: www.fda.gov Language: English Clinical pharmacology Food and Drug Administration Therapeutics United States Public Health Service Piperazines Biosimilar Ipilimumab Food and Drug Administration Amendments Act Moxifloxacin Pharmacology Clinical research Pharmaceutical sciences
32	Microsoft Word - Tables-Where can I go for help.doc Add to Reading List Source URL: www.fda.gov Language: English Medicine Center for Devices and Radiological Health ClinicalTrials.gov Center for Biologics Evaluation and Research Orphan drug Center for Drug Evaluation and Research Dermatologic and Ophthalmic Drugs Advisory Committee Oncology Drug Advisory Committee Food and Drug Administration Clinical research Health
33	DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Silver Spring MD 20993 Add to Reading List Source URL: www.fda.gov Language: English Lapatinib Organofluorides Quinazolines Sulfones Breast cancer treatment Food and Drug Administration Oncology Drug Advisory Committee Chemistry Organic chemistry GlaxoSmithKline
34	Federal Register / Vol. 72, No[removed]Thursday, August 16, [removed]Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 2007P–0074] Add to Reading List Source URL: www.gpo.gov Language: English - Date: 2014-05-29 12:13:36 Pharmaceutical sciences Center for Biologics Evaluation and Research National Cancer Institute Oncology Drug Advisory Committee Food and Drug Administration Medicine Health
35	The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus Add to Reading List Source URL: www.fda.gov Language: English Clinical research Center for Drug Evaluation and Research Merck & Co. Dermatologic and Ophthalmic Drugs Advisory Committee Oncology Drug Advisory Committee Food and Drug Administration Health Pharmaceutical sciences
36	CARDIOVASCULAR AND RENAL DRUGS ADVISORY COMMITTEE MEMBERS (Voting) Add to Reading List Source URL: www.fda.gov Language: English Health Clinical pharmacology Pharmacology Therapeutics United States Public Health Service Center for Drug Evaluation and Research Pediatric Hematology and Oncology Oncology Drug Advisory Committee Susan Shurin Medicine Food and Drug Administration Pharmaceutical sciences
37	November 30, 2010 Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee Meeting - Webcast Recording Add to Reading List Source URL: www.fda.gov Language: English Working time Food and Drug Administration Medicinal chemistry Pharmaceutical sciences Clinical research Break
38	FOOD AND DRUG ADMINISTRATION (FDA) Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Clinical pharmacology Therapeutics United States Public Health Service Center for Drug Evaluation and Research Boehringer Ingelheim Dermatologic and Ophthalmic Drugs Advisory Committee Oncology Drug Advisory Committee Food and Drug Administration Pharmaceutical sciences Clinical research
39	ONCOLOGIC DRUGS ADVISORY COMMITTEE MEMBERS (Voting) Add to Reading List Source URL: www.fda.gov Language: English Clinical research Clinical pharmacology Pharmacology Therapeutics United States Public Health Service Center for Drug Evaluation and Research Oncology Drug Advisory Committee Dermatologic and Ophthalmic Drugs Advisory Committee Medicine Food and Drug Administration Pharmaceutical sciences
40	ONCOLOGIC DRUGS ADVISORY COMMITTEE MEMBERS (Voting) Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Clinical pharmacology Therapeutics United States Public Health Service Center for Drug Evaluation and Research Oncology Drug Advisory Committee Dermatologic and Ophthalmic Drugs Advisory Committee Food and Drug Administration Pharmaceutical sciences Clinical research

UPDATE